Denys-Drash syndrome (DDS) by Piccione, Maria & Salzano, Emanuela
Cancer Prone Disease Section 
Short Communication 
Atlas Genet Cytogenet Oncol Haematol. 2016; 20(12) 625 
Atlas of Genetics and Cytogenetics 
in Oncology and Haematology 
INIST-CNRS OPEN ACCESS JOURNAL 
Denys-Drash syndrome (DDS) 
Maria Piccione, Emanuela Salzano 
Department of Sciences for Health Promotion and Mother and Child Care G. D'Alessandro, 
University of Palermo, Palermo, Italy. piccionemaria@libero.it; salzanoemanuela@gmail.com 
Published in Atlas Database: December 2015 
Online updated version : http://AtlasGeneticsOncology.org/Kprones/DenysDrashID10036.html 
Printable original version : http://documents.irevues.inist.fr/bitstream/handle/2042/66952/12-2015-DenysDrashID10036.pdf 
DOI: 10.4267/2042/66952
This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 2.0 France Licence. 
© 2016 Atlas of Genetics and Cytogenetics in Oncology and Haematology 
Identity 
Other names 
Drash syndrome 
Wilms tumor and pseudo- or true hermaphroditism 
Nephropathy, Wilms tumor, and genital anomalies 
Note 
Meacham Syndrome(OMIM # 608978) is an allelic 
disorder with some clinical features overlapping plus 
cardiac and pulmonary malformations. 
Inheritance 
To date about 150 patients with DDS have been 
described and its prevalence is largerly unknown 
(Mueller 1994). The inheritance pattern is autosomal 
dominant, but most reported cases resulted from a de 
novo mutation in germline cells or in earlier phases 
of embryonic development as postzygotic somatic 
event (Coppes et al.1992). 
Cytogenetics 
Deletion or chromosomal rearrangements of 11p13 
critical region are rarely reported: only 1 DDS case  
was found carrier of 11p13-p12 deletion and none 
with Frasier Syndrome (Jadresic et al.1991). 
However cytogenetic deletion involving 11p11 and 
11p13 are described in sporadic Wilms Tumor and 
in Wilms tumor in association to WAGR (Wilms 
tumor, aniridia, genitourinary anomalies and mental 
retardation) Syndrome (OMIM #194072). 
Genes involved and 
proteins 
Gene-phenotype 
Denys-Drash syndrome 194080 
Frasier syndrome 136680 
Meacham syndrome 608978 
Mesothelioma, somatic 156240 
Nephrotic syndrome, type 4 256370 
Wilms tumor, type 1 194070 
Comparison between Denys-Drash and Frasier Phenotypes. 
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WT1 (Wilms' tumor suppressor gene) 
Location 
11p13 
Note 
WT1 gene encodes for a DNA-binding protein 
including four zinc-finger motifs at the C-terminus 
and a proline/glutamine-rich DNA-binding domain 
at the N-terminus. It acts as trascriptional modulator 
that has an essential role in the normal development 
of the urogenital system. This gene has a biallelic, 
and monoallelic expression from the maternal and 
paternal alleles in different tissues. 
DNA/RNA 
Description 
10 exons, extending for 48 kb of genomic DNA. 
Transcription 
Alternative splicing at two sites results in four major 
different zinc finger protein isoforms (molecular 
weights of between 52 and 54 kDa). 
Protein 
Description 
Alternative splicing at the two sites generates 4 
major different isoforms, respectively either 
including or excluding exon 5 and including or 
excluding three amino-acids - lysine, threonine and 
serine (KTS positive or negative isoforms). The KTS 
isoforms are highly conserved throughout evolution, 
indicating a very biological important function. 
Expression 
Kidney, ovary, testis, liver, heart and hematopoietic 
cells. 
Localisation 
Mainly nuclear, depending on the different isoforms. 
Function 
WT1 mediates trascriptional activation and/or 
repression of several gene targets. It particular seems 
to directly synergize with SF1 participating to 
steroidogenesis and in sexual differentiation by 
regulating expression of the polypeptide hormone 
mullerian inhibiting substance. In addition WT1 
plays a key role in podocyte gene-expression and 
subsequently in podocyte differentiation (Nachtigat 
et al 1998; Lefebvre et al. 2015). 
Mutations 
Denys-Drash WT1 mutations are clustered 
particularly in the exons encoding Zf2 and Zf3in and 
behave as dominant negatives. Most WT1 mutations 
in rasier patients affect the exon 9 donor splice site 
resulting in a functional imbalance of WT1 +KTS 
isoforms, as detected on dysgenetic gonads by 
RTPCR (Klam et al.1998; Haber et al.1991). In 
addition transcriptional profiling of mice lacking the 
WT1 alternative splice isoform (+KTS) seems to 
have a more restrictive podocyte set of genes whose 
expression depends on these alternatively spliced 
isoforms (Klamt et al 1998; Lefebvre et al. 2015). 
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